Impact of FLT3-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study
Authors:
- Elizabeth M. CorleyECElizabeth M. Corley
- Moaath K. Mustafa AliMAMoaath K. Mustafa Ali
- Hanan AlharthyHAHanan Alharthy
- Kathryn A. F. KlineKKKathryn A. F. Kline
- Danielle SewellDSDanielle Sewell
- Jennie Y. LawJLJennie Y. Law
- Seung Tae LeeSLSeung Tae Lee
- Sandrine NiyongereSNSandrine Niyongere
- Vu H. DuongVDVu H. Duong
- Maria R. BaerMBMaria R. Baer
- Ashkan EmadiAEAshkan Emadi
Open Access
Abstract
The prognostic significance of the length of internal tandem duplication (ITD) insertions in mutant FLT3 genes in acute myeloid leukemia (AML) is controversial. We conducted a retrospective study to evaluate the correlation between the ITD base-pair (bp) insertion length and clinical outcomes. The mutational status of the FLT3 gene was evaluated in 402 of 467 consecutive AML patients treated at the University of Maryland Greenebaum Comprehensive Cancer Center between 2013 and 2020; 77 had FLT3-ITD mutations. Patients were divided into three cohorts based on bp insertion length (53 (>66th percentile)). The median overall survival (OS) of patients was 16.5 months (confidence interval (CI) 7.3-NA), 18.5 months (CI 7.3-NA), and 21.9 months (CI 19.1-NA) (p = 0.03) for the 53 bp insertion length cohorts, respectively. The adjusted median event-free survival (EFS) for the ITD insertion lengths >30, 30–53, and >53 bp was 11.1 months (CI 2.8–16.5), 5.2 months (CI 2.9–12.6), and 9.1 months (CI 5.4-NA) (p = 0.5), respectively. Complete remission (CR) rates were 64% (53 inserted bp) (p = 0.23). For patients treated with gilteritinib and midostaurin, the unadjusted median OS was not statistically significantly different between cohorts.Keywords
Funding Information
- National Cancer Institute - Cancer Center Support (CCSG, P30CA134274)
- Maryland Department of Health's Cigarette Restitution Fund Program (CCSG, P30CA134274)
This publication has 29 references indexed in Scilit:
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingNature, 2012
- FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AMLBlood, 2010
- Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research.Psychological Methods, 2010
- Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcomeBlood, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Structural and numerical variation of FLT3/ITD in pediatric AMLBlood, 2008
- More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML)Blood, 2006
- Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemiaBlood, 2006
- Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutationsBlood, 2005
- The Structural Basis for Autoinhibition of FLT3 by the Juxtamembrane DomainMolecular Cell, 2004